TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate
María Patricia Hernández-Mitre, Susan C. Morpeth, Balasubramanian Venkatesh, Thomas Hills, Joshua S. Davis, Robert K. Mahar, Grace McPhee, Mark Jones, James Totterdell, Steven Y. C. Tong, Jason A. Roberts
Topics & Concepts
TMPRSS2Serine proteaseSerine Proteinase InhibitorsPharmacologyRandomized controlled trialMeta-analysisProteaseMedicineCoronavirus disease 2019 (COVID-19)EnzymeBiologyInternal medicineBiochemistryDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchDiverse Scientific Research Studies